Marco Sanduzzi‐Zamparelli

机构：Hospital Clínic de Barcelona, Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas, Biomedical Research Institute, Consorci Institut D'Investigacions Biomediques August Pi I Sunyer, Universitat de Barcelona · ORCID：0000-0003-3795-3705

发表论文 59 篇 · 总被引 1443 次 · h-index 19

代表论文

• BCLC strategy for prognosis prediction and treatment recommendations: The 2026 update (2025 · Journal of Hepatology · 被引 186)
• Neutralizing GDF-15 can overcome anti-PD-1 and anti-PD-L1 resistance in solid tumours (2024 · Nature · 被引 125)
• Histological predictors of aggressive recurrence of hepatocellular carcinoma after liver resection (2024 · Journal of Hepatology · 被引 118)
• International Liver Cancer Association (ILCA) white paper on hepatocellular carcinoma risk stratification and surveillance (2023 · Journal of Hepatology · 被引 92)
• Neurological adverse events related to immune-checkpoint inhibitors in Spain: a retrospective cohort study (2023 · The Lancet Neurology · 被引 61)
• Outcome of patients with HCC and liver dysfunction under immunotherapy: a systematic review and meta-analysis (2023 · Hepatology · 被引 35)